The Treatment of Metastatic Non-small Cell Lung Cancer (NSCLC) in New Era of Personalised Medicine
Lung cancer is the leading cause of cancer related mortality in Canada and USA. Majority of the patients present in advanced stage of the disease and of these only about 2% will be alive at 5 years. NSCLC is the most common form of lung cancer, accounting for approximately 87% of cases. Systemic che...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Frontiers Media SA
2021
|
| Subjects: | |
| Online Access: | 18152 |
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: The Treatment of Metastatic Non-small Cell Lung Cancer (NSCLC) in New Era of Personalised Medicine
- Update on the Treatment of Metastatic Non-small Cell Lung Cancer (NSCLC) in New Era of Personalised Medicine
- Non-small Cell Lung Cancer: Current Therapies and New Targeted Treatments
- Novel Biomarkers in Non-Small Cell Lung Cancer (NSCLC)
- Prevention, Diagnosis and Treatments of Early-Stage NSCLC
- Precision Medicine in Solid Tumors
- Lung Cancer: Targets and Therapy